46. 悪性関節リウマチ Malignant rheumatoid arthritis Clinical trials / Disease details

臨床試験数 : 4,325 / 薬物数 : 2,671 - (DrugBank : 417) / 標的遺伝子数 : 187 - 標的パスウェイ数 : 224

30 trials found

diseases per page:

Showing 1 to 10 of 30 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2008-005320-81-ES (EUCTR)	18/02/2009	20/01/2009	Segundo estudio de extensión abierto de 2 años de duración para evaluar la seguridad tolerabilidad y ...	Segundo estudio de extensión abierto de 2 años de duración para evaluar la seguridad tolerabilidad y ...	Artritis Reumatoide MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid art ...	Product Name: ACZ885 Product Code: ACZ885 INN or Proposed INN: Canakinumab Other descriptive name: Reco ...	Novartis Farmacéutica S.A.	NULL	Not Recruiting			Female: yes Male: yes	160	Phase 2	Belgium;Spain;Austria;Germany
2	EUCTR2008-005320-81-BE (EUCTR)	16/02/2009	20/02/2009	A 2-year open-label second extension study to evaluate the safety, tolerability and efficacy of cana ...	A 2-year open-label second extension study to evaluate the safety, tolerability and efficacy of cana ...	Rheumatoid Arthritis MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: ACZ885 Product Code: ACZ885 INN or Proposed INN: Canakinumab Other descriptive name: Reco ...	Novartis Pharma Services AG	Novartis Pharma Belgium	Not Recruiting			Female: yes Male: yes			Spain;Belgium;Austria;Germany
3	EUCTR2008-005320-81-DE (EUCTR)	06/02/2009	17/11/2008	A 2-year open-label second extension study to evaluate the safety, tolerability and efficacy of cana ...	A 2-year open-label second extension study to evaluate the safety, tolerability and efficacy of cana ...	Rheumatoid Arthritis MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: ACZ885 Product Code: ACZ885 INN or Proposed INN: Canakinumab Other descriptive name: Reco ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	213		Germany;Spain;Austria
4	EUCTR2008-005320-81-AT (EUCTR)	21/10/2008	22/09/2008	A 2-year open-label second extension study to evaluate the safety, tolerability and efficacy of cana ...	A 2-year open-label second extension study to evaluate the safety, tolerability and efficacy of cana ...	Rheumatoid Arthritis MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: ACZ885 Product Code: ACZ885 INN or Proposed INN: Canakinumab Other descriptive name: Reco ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	200		Germany;Spain;Austria
5	EUCTR2007-001665-15-IT (EUCTR)	10/12/2007	05/10/2007	A 54-week, phase II, multi-center, open-label extension study to evaluate the efficacy, safety and t ...	A 54-week, phase II, multi-center, open-label extension study to evaluate the efficacy, safety and t ...	rheumatoid arthritis MedDRA version: 6.1;Level: PT;Classification code 10039073	Product Name: Canakinumab Product Code: ACZ885	NOVARTIS FARMA	NULL	Not Recruiting			Female: yes Male: yes	179	Phase 2	Germany;Netherlands;Spain;Italy
6	EUCTR2007-000491-16-AT (EUCTR)	06/12/2007	05/04/2007	A 76-week open-label extension study to evaluate the efficacy, safety and tolerability of ACZ885(ant ...	A 76-week open-label extension study to evaluate the efficacy, safety and tolerability of ACZ885(ant ...	Rheumatoid Arthritis MedDRA version: 8.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Code: ACZ885 INN or Proposed INN: Canakinumab (proposed) Other descriptive name: ACZ885 Drug Sub ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	260		Germany;Spain;Austria
7	EUCTR2007-001665-15-NL (EUCTR)	09/11/2007	17/10/2007	A 54-week, phase II, multi-center, open-label extension study to evaluate the efficacy, safety and t ...	A 54-week, phase II, multi-center, open-label extension study to evaluate the efficacy, safety and t ...	Rheumatoid Arthritis MedDRA version: 8.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Code: ACZ885 INN or Proposed INN: Canakinumab (proposed) Other descriptive name: ACZ885 Drug Sub ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	179	Phase 2	Germany;Netherlands;Spain;Italy
8	EUCTR2007-001665-15-DE (EUCTR)	16/10/2007	30/07/2007	A 54-week, phase II, multi-center, open-label extension study to evaluate the efficacy, safety and t ...	A 54-week, phase II, multi-center, open-label extension study to evaluate the efficacy, safety and t ...	Rheumatoid Arthritis MedDRA version: 8.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Code: ACZ885 INN or Proposed INN: Canakinumab (proposed)	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	179	Phase 2	Germany;Netherlands;Spain;Italy
9	NCT00554606 (ClinicalTrials.gov)	October 2007	5/11/2007	Long-term Efficacy, Safety and Tolerability of ACZ885 in Patients With Rheumatoid Arthritis	A 54-week, Phase II, Multi-center, Open-label Extension Study to Evaluate the Efficacy, Safety and T ...	Rheumatoid Arthritis	Drug: ACZ885	Novartis	NULL	Completed	18 Years	75 Years	All	115	Phase 2	United States;Belgium;Germany;Italy;Netherlands;Russian Federation;Spain;Switzerland;Turkey
10	EUCTR2007-001665-15-ES (EUCTR)	14/09/2007	27/06/2007	Estudio de extensión abierto, multicéntrico, de fase II, de 54 semanas de duración, para evaluar la ...	Estudio de extensión abierto, multicéntrico, de fase II, de 54 semanas de duración, para evaluar la ...	Artritis Reumatoide MedDRA version: 8.1;Level: LLT;Classification code 10039073;Term: Rheumatoid art ...	Product Code: ACZ885 INN or Proposed INN: Canakinumab (proposed) Other descriptive name: ACZ885 Drug Sub ...	Novartis Farmaceutica S.A.	NULL	Not Recruiting			Female: yes Male: yes	179		Belgium;Spain;Netherlands;Germany;Italy

First Previous1 2 3Next Last